Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities

被引:41
作者
Meng, Lei [1 ,2 ]
Li, Xin-Yu [1 ,2 ]
Shen, Liang [1 ,2 ]
Ji, Hong-Fang [1 ,2 ]
机构
[1] Shandong Univ Technol, Inst Biomed Res, Zibo, Shandong, Peoples R China
[2] Shandong Univ Technol, Shandong Prov Res Ctr Bioinformat Engn & Tech, Sch Life Sci, Zibo Key Lab New Drug Dev Neurodegenerat Dis, Zibo, Shandong, Peoples R China
关键词
AMYLOID-BETA-PROTEIN; GAMMA AGONIST PIOGLITAZONE; MILD COGNITIVE IMPAIRMENT; MODULATING TAU HYPERPHOSPHORYLATION; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; MOUSE MODEL; MEMORY IMPAIRMENT; INTRANASAL INSULIN; RECEPTOR AGONIST; PPAR-GAMMA;
D O I
10.1016/j.molmed.2020.02.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) represent two major health burdens with steadily increasing prevalence and accumulating evidence indicates a close relationship between the two disorders. In view of their similar pathogenesis, the potential of T2DM drugs for the treatment of AD has attracted considerable attention in recent years, with inspiring outcomes. Here, we provide a comprehensive overview of the effects of a total of 14 individual drugs (among which are seven T2DM drug types) against AD. Further, we discuss the potential action mechanisms of these T2DM drugs against AD. We argue that these findings may open novel avenues for AD drug discovery, drug target identification, and cotreatment of the two disorders.
引用
收藏
页码:597 / 614
页数:18
相关论文
共 114 条
[1]   Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition [J].
Adler, Brittany L. ;
Yarchoan, Mark ;
Hwang, Hae Min ;
Louneva, Natalia ;
Blair, Jeffrey A. ;
Palm, Russell ;
Smith, Mark A. ;
Lee, Hyoung-gon ;
Arnold, Steven E. ;
Casadesus, Gemma .
NEUROBIOLOGY OF AGING, 2014, 35 (04) :793-801
[2]   Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[3]   Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy [J].
Barini, Erica ;
Antico, Odetta ;
Zhao, Yingjun ;
Asta, Francesco ;
Tucci, Valter ;
Catelani, Tiziano ;
Marotta, Roberto ;
Xu, Huaxi ;
Gasparini, Laura .
MOLECULAR NEURODEGENERATION, 2016, 11
[4]   The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease [J].
Batista, Andre F. ;
Forny-Germano, Leticia ;
Clarke, Julia R. ;
Lyra e Silva, Natalia M. ;
Brito-Moreira, Jordano ;
Boehnke, Susan E. ;
Winterborn, Andrew ;
Coe, Brian C. ;
Lablans, Ann ;
Vital, Juliana F. ;
Marques, Suelen A. ;
Martinez, Ana M. B. ;
Gralle, Matthias ;
Holscher, Christian ;
Klein, William L. ;
Houzel, Jean-Christophe ;
Ferreira, Sergio T. ;
Munoz, Douglas P. ;
De Felice, Fernanda G. .
JOURNAL OF PATHOLOGY, 2018, 245 (01) :85-100
[5]   PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS [J].
Bellelli, Giuseppe ;
Morghen, Sara ;
Torpilliesi, Tiziana ;
Trabucchi, Marco .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (01) :178-179
[6]   Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals [J].
Bomba, M. ;
Ciavardelli, D. ;
Silvestri, E. ;
Canzoniero, L. M. T. ;
Lattanzio, R. ;
Chiappini, P. ;
Piantelli, M. ;
Di Ilio, C. ;
Consoli, A. ;
Sensi, S. L. .
CELL DEATH & DISEASE, 2013, 4 :e612-e612
[7]   Vascular risks and incident dementia: Results from a cohort study of the very old [J].
Brayne, C ;
Gill, C ;
Huppert, FA ;
Barkley, C ;
Gehlhaar, E ;
Girling, DM ;
O'Connor, DW ;
Paykel, ES .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1998, 9 (03) :175-180
[8]   LIXISENATIDE RESCUES SPATIAL MEMORY AND SYNAPTIC PLASTICITY FROM AMYLOID β PROTEIN-INDUCED IMPAIRMENTS IN RATS [J].
Cai, H. -Y. ;
Hoelscher, C. ;
Yue, X. -H. ;
Zhang, S. -X. ;
Wang, X. -H. ;
Qiao, F. ;
Yang, W. ;
Qi, J. -S. .
NEUROSCIENCE, 2014, 277 :6-13
[9]   Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis [J].
Cao, Bing ;
Rosenblat, Joshua D. ;
Brietzke, Elisa ;
Park, Caroline ;
Lee, Yena ;
Musial, Natalie ;
Pan, Zihang ;
Mansur, Rodrigo B. ;
McIntyre, Roger S. .
DIABETES OBESITY & METABOLISM, 2018, 20 (10) :2467-2471
[10]   Metformin Alleviated Aβ-Induced Apoptosis via the Suppression of JNK MAPK Signaling Pathway in Cultured Hippocampal Neurons [J].
Chen, Bin ;
Teng, Ying ;
Zhang, Xingguang ;
Lv, Xiaofeng ;
Yin, Yanling .
BIOMED RESEARCH INTERNATIONAL, 2016, 2016